Buy Methadone Online USA, In cities across the country, morning is peak time at almost any opioid treatment program. The line stretches from the front counter to the back door as patients wait to get their daily dose of methadone. It’s an absolutely essential gathering, but one that runs counter to containing the Covid-19 outbreak.
Efforts by health systems and governments to contain the spread of SARS-CoV-2, the novel coronavirus that causes the disease, have revealed gaping cracks in our nation’s public health and safety net infrastructure. The virus appears to have an outsized effect on vulnerable Americans. We have already seen in a Seattle nursing home how quickly the virus travels in close quarters. It is likely to do the same among the homeless and those who are incarcerated. Missing from the national discussion has been another vulnerable group: patients like ours with opioid use disorder. Buy Methadone Online USA
Despite ongoing public health efforts, the opioid overdose crisis does not appear to be slowing down. The emergency of Covid-19 could worsen it if we do not preemptively develop and implement response plans.
The Centers for Disease Control and Prevention currently recommends social isolation as a key measure for individuals to prevent getting infected and to curb spreading it to others. Many patients taking medications to treat their opioid use disorder — methadone or buprenorphine — aren’t able to stay home because of government regulations that limit how these medications are prescribed and dispensed.
In the United States, methadone can be dispense only at highly regulate and monitore opioid treatment programs. There are more than 1,250 such programs across the country that treat more than 350,000 people. Strict rules require most of the people to show up at the program every day to get their dose of methadone. A single opioid treatment program may see thousands of patients a day, a scenario that could foster the spread of the coronavirus.
So how will these patients stay safe? Although the Substance Abuse and Mental Health Services Administration (SAMHSA) recently release a guide for opioid treatment programs dispensing methadone during the Covid-19 outbreak, implementing the guidelines is contingent on state regulations and falls short of what is need.
In the past, experts have called for updated regulations that allow office-based methadone treatment, but nothing has budged. There is now an urgency for this change to occur.
In the setting of an outbreak of a highly contagious infectious disease, requiring patients with opioid.
use disorder to come to an opioid treatment program to get the medication they need to fight their addiction.
First, individuals will continue to come and get their medication even though they have symptoms of Covid-19.
SO possibly exposing other patients passing through the program and the medical staff caring for them to the virus. A second possibility is that individuals will not or cannot come because of infection.
leading to missed medication doses followed by opioid withdrawal and increased risk of recurrent drug use and overdose.